Global OTC Analgesics Market is Estimated to Surpass Revenues Worth US$ 20,000 Mn by 2022 End

The market for OTC analgesics is foreseen to possess high potential for growth, with surging sales and demand for pain medication including pain killers, and pain relievers. High demand has been witnessed for narcotic pain medication on the back of adverse effects on patients consuming narcotic drugs. The market for OTC analgesics will witness an impressive growth in both developing as well as the developed economies, creating opportunities for topical analgesic distributors and manufacturers in the near future. A recent report by Fact.MR provides an in-depth analysis about the global OTC analgesics market for the forecast period 2017 to 2022. The report’s primary objective is to provide information and updates pertaining to growth opportunities in the global market for OTC analgesics.

The scope of Fact.MR’s report is to analyze the global OTC analgesics market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Drug manufacturers, stakeholders, and suppliers in the global healthcare sector can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and journals pertaining to OTC analgesics.

Request Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=75

6 Prospects of the Global OTC Analgesics Market

1. In terms of revenues, North America is expected to hold the largest share of the market, and will remain dominant in the global market for OTC analgesics over the forecast period.

2. Europe will continue to be the second largest market for OTC analgesics, while the market in Japan is expected to register a relatively higher CAGR than the market in Europe through 2022.

3. Pharmacy is expected to be the most lucrative OTC channel for OTC analgesics in the global market, followed by drug store and online store.

4. Sales of OTC analgesics in online store and modern trade OTC channels are anticipated to register the highest CAGRs through 2022.

5. In terms of revenues, tablet form of OTC analgesics is estimated to account for more than half share of the market throughout the forecast period. Tablet OTC analgesics will continue to be sought-after among consumers across the globe.

6. Capsule is expected to remain the second largest adopted product form of OTC analgesics in the market, with sales exhibiting the highest CAGR through 2022.

Browse Full Report with TOC- https://www.factmr.com/report/75/otc-analgesics-market

Pharmacy to Remain the Most Lucrative OTC Channel in the Global OTC Analgesics Market

Pharmacy will remain the most lucrative OTC channel for sales of OTC analgesics in the market. Drug store is expected to be the second largest OTC channel in the market. OTC analgesics sales in online store, and the modern trade OTC channels will register the fastest expansion through 2022.

North America will continue to account for the largest revenue share of the market, and is estimated to retain its dominance in the global OTC analgesics market over the forecast period. In addition, Europe will remain the second most lucrative market for OTC analgesics, however the market in Japan will register a relatively faster expansion than in Europe through 2022.

OTC analgesics in the form of tablets will account for more than half revenue share of the market over the forecast period. In addition, tablet OTC analgesics are anticipated to remain sought-after among consumers around the world. Capsule will continue to be the second largest sold OTC analgesics product in the global market, with sales expanding at the highest CAGR throughout the forecast period.

Competition Tracking

Key market players mentioned in Fact.MR’s report include Sun Pharmaceuticals Industries Limited, Johnson & Johnson Service, Inc., AstraZeneca Plc., Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., and Pfizer Inc.

Check Discount- https://www.factmr.com/connectus/sample?flag=D&rep_id=75

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

This release was published on openPR.